Titre : | 3-CMC. Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) |
Accompagne : | |
Auteurs : | OEDT = EMCDDA |
Type de document : | Rapport |
Editeur : | Lisbon : OEDT / EMCDDA, 2022 |
Collection : | Risk assessments, ISSN 1725-4493 |
ISBN/ISSN/EAN : | 978-92-9497-703-8 |
Format : | 90 p. |
Langues: | Anglais |
Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
Mots-clés : |
Organismes OEDTThésaurus TOXIBASE CONTROLE DES STUPEFIANTS ; PHARMACOLOGIE ; FACTEUR DE RISQUE ; TOXICOLOGIE ; CATHINONES ; REGLEMENTATION ; DROGUES DE SYNTHESE ; CHIMIE ; TOXICITE |
Résumé : | This publication presents the data and findings of the risk assessment on 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC), carried out by the extended Scientific Committee of the EMCDDA on 19 November 2021. On the basis of the Risk Assessment Report, on 18 March 2022, the Commission decided that 3-CMC should be included in the definition of 'drug', in the Annex to Framework Decision 2004/757/JHA. |
Note de contenu : |
TABLE OF CONTENTS:
- EMCDDA Initial Report on 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC). - Risk assessment report on a new psychoactive substance: 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC). - Annex 1: Technical report on the new psychoactive substance 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC). - Annex 2: Participants of the risk assessment meeting, 19 November 2021. |
Domaine : | Drogues illicites / Illicit drugs |
URL : | News release (18/03/2022) |
Lien : | https://www.emcdda.europa.eu/publications/risk-assessments/3-cmc_en |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Documents numériques (1)
![]() EMCDDA_RAR_3-CMC_2022.pdf Adobe Acrobat PDF |
